Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Karyopharm Therapeutics I...

    NASDAQ: KPTI · Real-Time Price · USD
    4.40
    0.04 (0.92%)
    At close: Jun 13, 2025, 3:59 PM
    4.50
    2.27%
    After-hours: Jun 13, 2025, 05:56 PM EDT

    Karyopharm Therapeutics Statistics

    Share Statistics

    Karyopharm Therapeutics has 8.64M shares outstanding. The number of shares has increased by 0.8% in one year.

    Shares Outstanding

    n/a
    		 8.64M

    Shares Change (YoY)

    n/a
    		 0.8%

    Shares Change (QoQ)

    n/a
    		 -0.46%

    Owned by Institutions (%)

    n/a
    		 49.99%

    Shares Floating

    n/a
    		 7.96M

    Failed to Deliver (FTD) Shares

    n/a
    		 17,253

    FTD / Avg. Volume

    n/a
    		 15.21%

    Short Selling Information

    The latest short interest is 2.07M, so 24% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.07M

    Short % of Shares Out

    n/a
    		 24%

    Short % of Float

    n/a
    		 24.19%

    Short Ratio (days to cover)

    n/a
    		 28.52

    Valuation Ratios

    The PE ratio is -16.17 and the forward PE ratio is -0.64. Karyopharm Therapeutics's PEG ratio is 0.33.

    PE Ratio

    n/a
    		 -16.17

    Forward PE

    n/a
    		 -0.64

    PS Ratio

    n/a
    		 8.51

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 -6.64

    P/FCF Ratio

    n/a
    		 -9.68

    PEG Ratio

    n/a
    		 0.33
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Karyopharm Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.7, with a Debt / Equity ratio of -1.05.

    Current Ratio

    n/a
    		 1.7

    Quick Ratio

    n/a
    		 1.64

    Debt / Equity

    n/a
    		 -1.05

    Debt / EBITDA

    n/a
    		 -5.04

    Debt / FCF

    n/a
    		 -1.52

    Interest Coverage

    n/a
    		 -3.19

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $520,562.72

    Profits Per Employee

    n/a
    		 $-273,913.98

    Employee Count

    n/a
    		 279

    Asset Turnover

    n/a
    		 0.88

    Inventory Turnover

    n/a
    		 1.27

    Taxes

    Income Tax

    n/a
    		 57K

    Effective Tax Rate

    n/a
    		 -0.07%

    Stock Price Statistics

    The stock price has increased by -69.34% in the last 52 weeks. The beta is 0.23, so Karyopharm Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.23

    52-Week Price Change

    n/a
    		 -69.34%

    50-Day Moving Average

    n/a
    		 5.04

    200-Day Moving Average

    n/a
    		 9.07

    Relative Strength Index (RSI)

    n/a
    		 42.39

    Average Volume (20 Days)

    n/a
    		 113,447

    Income Statement

    In the last 12 months, Karyopharm Therapeutics had revenue of 145.24M and earned -76.42M in profits. Earnings per share was -0.63.

    Revenue

    n/a
    		 145.24M

    Gross Profit

    n/a
    		 139.23M

    Operating Income

    n/a
    		 -119.44M

    Net Income

    n/a
    		 -76.42M

    EBITDA

    n/a
    		 -38.6M

    EBIT

    n/a
    		 -38.94M

    Earnings Per Share (EPS)

    n/a
    		 -0.63
    Full Income Statement

    Balance Sheet

    The company has 62.48M in cash and 194.52M in debt, giving a net cash position of -132.05M.

    Cash & Cash Equivalents

    n/a
    		 62.48M

    Total Debt

    n/a
    		 194.52M

    Net Cash

    n/a
    		 -132.05M

    Retained Earnings

    n/a
    		 -1.56B

    Total Assets

    n/a
    		 127.71M

    Working Capital

    n/a
    		 29.87M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -127.49M and capital expenditures -142K, giving a free cash flow of -127.63M.

    Operating Cash Flow

    n/a
    		 -127.49M

    Capital Expenditures

    n/a
    		 -142K

    Free Cash Flow

    n/a
    		 -127.63M

    FCF Per Share

    n/a
    		 -1.05
    Full Cash Flow Statement

    Margins

    Gross margin is 95.86%, with operating and profit margins of -82.24% and -52.62%.

    Gross Margin

    n/a
    		 95.86%

    Operating Margin

    n/a
    		 -82.24%

    Pretax Margin

    n/a
    		 -52.58%

    Profit Margin

    n/a
    		 -52.62%

    EBITDA Margin

    n/a
    		 -26.58%

    EBIT Margin

    n/a
    		 -82.24%

    FCF Margin

    n/a
    		 -87.88%

    Dividends & Yields

    KPTI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for KPTI is $42, which is 854.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $42

    Price Target Difference

    n/a
    		 854.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 26, 2025. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Feb 26, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -16.99

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist